跳至主要内容
临床试验/NCT06512090
NCT06512090尚未招募不适用

To Investigate the Effects of Low Glycemic Index(LGI)Related Steamed Bread on Glycemia Control, Islet Function in Patients With Type 2 Diabetes in China: A Single-center, Randomized, Open-label, Prospective Study

Shanghai Punan Hospital of Pudong New District0 个研究点目标入组 144 人开始时间: 2024年7月13日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
144
主要终点
glucose at 120 mins

研究概览

简要总结

This was a single-center, randomized, open, prospective, parallel-controlled, head-to-head comparison trial. To investigate the effects of low glycemic index(LGI)related steam bread on glycemic control,islet function in patients with type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18yrs;
  • Diagnosed as Type 2 Diabetes;
  • Had been on a stable hypoglycemic regimen for at least 30 days prior to screening;
  • HbA1c between 7.5% and 11.0% (both upper and lower limits included) in the 90 days prior to screening;
  • Fasting C-peptide ≥1.0ng/ml in the 90 days prior to screening;
  • Be willing to accept and adhere to LGI steamed bread as a staple food for at least 14 days

排除标准

  • Diagnosed with type 1 diabetes, or secondary diabetes;
  • Have clinically significant liver disease, moderate/severe kidney injury, or end-stage renal disease;
  • Has unstable CV disorders, including heart failure (NYHA) class III or IV), intractable angina, uncontrolled arrhythmias, and severe uncontrolled hypertension (systolic blood pressure ≥180mmHg, or diastolic blood pressure ≥105mmHg);
  • An Acute Coronary Syndrome event (ACS) occurred within the 6 months prior to randomization

结局指标

主要结局

glucose at 120 mins

时间窗: 120 minutes

the blood glucose level at 120 mins after Standard meal test

次要结局

  • iAUC 120 minutes(120 minutes)
  • glucose at 60 mins(60 minutes)

研究者

发起方
Shanghai Punan Hospital of Pudong New District
申办方类型
Other
责任方
Sponsor

相似试验

Effects of LGI Steam Bread on Glycemia Control in... | 临床试验